Table 2.
Risk category | Age groups (years) | ||||
---|---|---|---|---|---|
0–4 | 5–9 | 10–14 | 15–17 | All ages | |
OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | |
Influenza season 2017–18 | |||||
Lung disease | 3.0 (2.1–4.2) | 4.5 (2.4–7.8) | 2.6 (0.8–6.3) | 5.8 (2.4–12.3) | 4.0 (3.0–5.1) |
Asthma | 2.4 (1.5–3.7) | 2.7 (1.0–6.0) | n.a. | 6.3 (2.2–14.7) | 2.9 (2.0–4.1) |
Heart conditions | 6.2 (2.0–14.7) | 30.6 (12.0–65.6) | n.a. | n.a. | 7.6 (3.9–13.3) |
Neurological disease or sequelae | 5.8 (2.5–11.5) | 11.8 (5.5–22.5) | 26.7 (14.0–47.8) | 16.9 (7.3–34.6) | 10.1 (7.2–13.9) |
Epilepsy | 6.8 (2.2–16.1) | 16.2 (7.2–32.0) | 25.1 (11.5–49.4) | 23.4 (9.6–49.6) | 12.1 (8.2–17.3) |
Immunocompromised | 11.4 (5.6–20.7) | 44.5 (22.8–79.9) | 35.1 (13.5–76.7) | n.a. | 18.3 (12.3–26.4) |
All patients with one or more risk condition | 6.1 (5.0–7.4) | ||||
Influenza season 2018–19 | |||||
Lung disease | 4.1 (3.0–5.6) | 4.4. (1.9–9.0) | n.a. | n.a. | 4.7 (3.5–6.1) |
Asthma | 2.5 (1.6–3.9) | n.a. | n.a. | n.a. | 2.4 (1.5–3.7) |
Heart conditions | n.a. | n.a. | n.a. | n.a. | n.a. |
Neurological disease or sequelae | 11.0 (6.1–18.6) | 17.6 (7.7–35.7) | n.a. | n.a. | 7.0 (4.4–10.5) |
Epilepsy | 16.9 (8.6–30.1) | 23.8 (9.8–49.9) | n.a. | n.a. | 9.2 (5.6–14.4) |
Immunocompromised | 8.9 (4.0–17.1) | 26.1 (8.2–64.1) | n.a. | 53.9 (16.0–144.6) | 13.6 (8.1–21.6) |
All patients with one or more risk condition |
6.8 (5.4–8.4) |
n.a. = not applicable due to low numbers